European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Czechia — market report, February 2026

Oncology drug tenders in Czechia in February 2026: 103 tenders published (+26% month on month, +21% year on year), estimated at €40,864,527 in total, and 104 contracts awarded (+17% month on month, -10% year on year), worth €36,284,640 (awarded value). Buyers with the most tenders: Fakultní nemocnice Ostrava (11), Revmatologický ústav (4) and Fakultní nemocnice Olomouc (4); most contracts won: ROCHE s.r.o. (15), Amgen s.r.o. (7) and Janssen-Cilag s.r.o. (6). On average 3.3 bids per contract; 75% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
103
Contracts awarded
104
Contract value awarded
€36,284,640
Bids per contract
3.3
Tenders published per month
050100150Feb 25: 85Feb 25: 85Feb 25Mar 25: 105Mar 25: 105Mar 25Apr 25: 88Apr 25: 88Apr 25May 25: 82May 25: 82May 25Jun 25: 86Jun 25: 86Jun 25Jul 25: 92Jul 25: 92Jul 25Aug 25: 96Aug 25: 96Aug 25Sep 25: 76Sep 25: 76Sep 25Oct 25: 118Oct 25: 118Oct 25Nov 25: 72Nov 25: 72Nov 25Dec 25: 84Dec 25: 84Dec 25Jan 26: 82Jan 26: 82Jan 26Feb 26: 103Feb 26: 103103Feb 26
Contracts awarded per month
0100200300Feb 25: 115Feb 25: 115Feb 25Mar 25: 235Mar 25: 235Mar 25Apr 25: 179Apr 25: 179Apr 25May 25: 174May 25: 174May 25Jun 25: 146Jun 25: 146Jun 25Jul 25: 125Jul 25: 125Jul 25Aug 25: 115Aug 25: 115Aug 25Sep 25: 128Sep 25: 128Sep 25Oct 25: 166Oct 25: 166Oct 25Nov 25: 143Nov 25: 143Nov 25Dec 25: 107Dec 25: 107Dec 25Jan 26: 89Jan 26: 89Jan 26Feb 26: 104Feb 26: 104104Feb 26

The highlighted bar is February 2026. Hover a bar for its figure; the table below has every value.

FigureFebruary 2026January 2026ChangeFebruary 2025Change
Tenders published10382+26%85+21%
Estimated value€40,864,527€27,869,314+47%€95,718,477-57%
Buyers10100%9+11%
Contracts awarded10489+17%115-10%
Contract value (awarded)€36,284,640€18,018,344+101%€14,172,158+156%
Winners1314-7%12+8%
Bids per contract3.32.0—7.5—
Single-bid contracts75%61%—58%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Hlavní město Praha 23
  • Královéhradecký kraj 18
  • Moravskoslezský kraj 8
  • Olomoucký kraj 4
  • Ústecký kraj 2

Procedures

  • not stated 48
  • Open procedure 33
  • Other procedure 22

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Czechia in February 2026?
103 (by 10 buyers); for comparison, January 2026: 82, February 2025: 85.
Who won the most oncology drug tenders in Czechia in February 2026?
By number of contracts: ROCHE s.r.o. (15), Amgen s.r.o. (7), Janssen-Cilag s.r.o. (6), Merck Sharp & Dohme s.r.o. (5) and Gilead Sciences s.r.o. (4); 13 companies won contracts in all.
Which buyers published the most oncology drug tenders in February 2026?
Fakultní nemocnice Ostrava (11), Revmatologický ústav (4), Fakultní nemocnice Olomouc (4), Institut klinické a experimentální medicíny (4) and Oblastní nemocnice Mladá Boleslav, a.s., nemocnice Středočeského kraje (3).
How competitive were oncology drug tenders in Czechia in February 2026?
On average 3.3 bids per contract (56 contracts with a known number of bids); 75% of contracts had a single bid.
What were the contracts worth in February 2026?
€36,284,640 (awarded value, 104 contracts); median about €550,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.